Nicolette Sherman
Presidente presso Deirdres House
Patrimonio netto: 412 868 $ in data 31/05/2024
Profilo
Nicolette D.
Sherman's current job is Chairman at Deirdres House.
Ms. Sherman's former jobs include being the VP-North America Human Resources Operations at Sanofi Corp.
from 2008 to 2020, the Chief Human Resources Officer at Oyster Point Pharma, Inc. from 2020 to 2021, and the Chief Human Resources Officer at Certara, Inc. from 2021 to 2024.
Ms. Sherman's education history includes a graduate degree from Rutgers State University of New Jersey, an undergraduate degree from Lehigh University, and a graduate degree from the University of Delaware.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CERTARA, INC.
0.02% | 01/04/2024 | 24 358 ( 0.02% ) | 412 868 $ | 31/05/2024 |
Posizioni attive di Nicolette Sherman
| Società | Posizione | Inizio |
|---|---|---|
| Deirdres House | Presidente | - |
Precedenti posizioni note di Nicolette Sherman
| Società | Posizione | Fine |
|---|---|---|
| CERTARA, INC. | Ufficiale delle Risorse Umane | 21/05/2024 |
| OYSR POIN | Ufficiale delle Risorse Umane | 01/07/2021 |
| Sanofi Corp. | Corporate Officer/Principal | 01/04/2020 |
Formazione di Nicolette Sherman
| Rutgers State University of New Jersey | Graduate Degree |
| University of Delaware | Graduate Degree |
| Lehigh University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Aziende private | 3 |
|---|---|
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Pharmaceuticals: MajorHealth Technology Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ. | Health Technology |
| Sanofi Corp. | |
| Deirdres House |
- Borsa valori
- Insiders
- Nicolette Sherman
